Circassia Pharmaceuticals Plc announced the changes to its board of directors. Jo Le Couilliard is appointed as a Non-Executive Director with immediate effect. Jo was most recently Senior Vice President, Global Commercial Transformation at GlaxoSmithKline, and brings significant commercial and international pharmaceutical industry experience to Circassia. She was previously a Non-Executive Director of the Frimley Park Hospital NHS Foundation Trust. Sharon Curran is appointed as a Non-Executive Director with immediate effect. Sharon was most recently Vice President, Global Specialty Franchise and Customer Excellence at Abbvie Inc. She brings extensive commercial and specialty pharmaceutical experience to the company having held a number of senior roles at Abbvie, Abbott and Eli Lilly. Dr. Heribert Staudinger is appointed as a Non-Executive Director with immediate effect. Heribert is currently Immunology Clinical Lead at Sanofi Genzyme and brings extensive respiratory medicine development expertise to Circassia. During his 30 year career in pharmaceutical development he has held a number of leadership roles at Boehringer Ingelheim, Chiesi, Merck and Schering Plough. Dr. Jean-Jacques Garaud and Marvin S Samson will retire from the Board at the company's 2018 annual general meeting, and will therefore not seek re-election as Non-Executive Directors. In light of the appointments and retirements outlined the Board will make the changes to its Committees, and Lota S Zoth will become Senior Independent Non-Executive Director, effective from the date of the company's 2018 annual general meeting. Current Remuneration Committee Member Lota S Zoth will become Chair. She will be joined by Jo Le Couilliard and Sharon Curran as Committee Members. Jo Le Couilliard will join as Chair of Audit and Risk Committee, succeeding Lota S Zoth, who will continue as a Committee Member. They will be joined by Sharon Curran as a Committee Member. Francesco Granata will continue as Chair of Nomination Committee and will be joined by Jo Le Couilliard and Dr. Heribert Staudinger as Committee Members.